英文名称 | 中文名称 | CAS | MF |
Cyclobutanecarboxaldehyde, 2-[(acetyloxy)methyl]-, (1R,2R)- (9CI)
|
Cyclobutanecarboxaldehyde, 2-[(acetyloxy)methyl]-, (1R,2R)- (9CI)
|
371784-53-1
|
C8H12O3
|
Pyridine, 5-methyl-2-(1-propynyl)- (9CI)
|
|
371784-97-3
|
C9H9N
|
triphenylene-1,5,9-triamine
|
苯并菲-1,5,9-三胺
|
371786-11-7
|
C18H15N3
|
1H-Pyrrole-2-aceticacid,3,5-dimethyl--alpha--oxo-,methylester(9CI)
|
|
371786-24-2
|
C9H11NO3
|
4,1-(Nitrilometheno)-1H-pyrrolo[2,3-d]pyrimidine(9CI)
|
|
371786-48-0
|
C7H4N4
|
4,1-(Nitrilometheno)-1H-pyrrolo[3,2-d]pyrimidine(9CI)
|
|
371786-49-1
|
C7H4N4
|
1-HydroxyMethyl-1-(trifluoroMethyl)cyclobutane
|
1-(三氟甲基)-1-环丁基-1-甲醇
|
371917-16-7
|
C6H9F3O
|
1-(Trifluoromethyl)cyclopropanemethanol
|
1-(三氟甲基)环丙烷甲醇
|
371917-17-8
|
C5H7F3O
|
Cyclopentane, 1-methyl-1-(trifluoromethyl)- (9CI)
|
|
371917-22-5
|
C7H11F3
|
Cyclobutanecarboxaldehyde, 1-(trifluoromethyl)- (9CI)
|
|
371917-31-6
|
C6H7F3O
|
1-PHENYL-3-PYRIDIN-4-YL-1H-PYRAZOLE-4-CARBALDEHYDE
|
1-苯-3-吡啶-4-基-1H-吡唑-4-甲醛
|
371917-81-6
|
C15H11N3O
|
2-[(5-bromo-2-oxo-1-propyl-1,2-dihydro-3H-indol-3-ylidene)methyl]-3-ethyl-4(3H)-quinazolinone
|
|
371924-94-6
|
C22H20BrN3O2
|
2-imino-1-(2-methoxyethyl)-3-[(4-methylphenyl)sulfonyl]-1,2-dihydro-5H-dipyrido[1,2-a:2,3-d]pyrimidin-5-one
|
|
371927-44-5
|
C21H20N4O4S
|
3-[(4-Ethoxy-benzylidene)-amino]-2-methyl-3H-quinazolin-4-one
|
|
371929-96-3
|
C18H17N3O2
|
1-isopropyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinoline-4-carbonitrile
|
|
371930-42-6
|
C13H16N2O
|
Isoxazole, 3-(2-chloroethyl)-4,5-dimethyl- (9CI)
|
|
371932-99-9
|
C7H10ClNO
|
2H-Imidazo[4,5-b]pyridin-2-one, 7-amino-1,3-dihydro- (9CI)
|
|
371933-31-2
|
C6H6N4O
|
1H-Pyrrole-3-carboxylicacid,4-acetyl-2,5-dimethyl-,ethylester(9CI)
|
|
371933-91-4
|
C11H15NO3
|
PIK-inhibitors
|
PIK抑制剂
|
371934-59-7
|
C19H17N5O2
|
PI-103
|
PI-103
|
371935-74-9
|
C19H16N4O3
|
1-[4-(1,3-benzothiazol-2-ylsulfanyl)-3-nitrophenyl]ethanone
|
|
371935-76-1
|
C15H10N2O3S2
|
PI-103 (Hydrochloride)
|
PI-103 (Hydrochloride)
|
371935-79-4
|
C19H17ClN4O3
|
1,2,4-Oxadiazole-3-carboximidamide,5-amino-N-hydroxy-
|
|
371935-95-4
|
C3H5N5O2
|
1H-Pyrazolo[4,3-d]pyrimidine-5,7(4H,6H)-dione, 4-methyl-3-(2-propenylamino)- (9CI)
|
|
371936-76-4
|
C9H11N5O2
|
1H-Imidazol-2-amine,N-ethyl-1-methyl-4-nitro-(9CI)
|
|
371939-78-5
|
C6H10N4O2
|
6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide
|
6-氨基-N-[3-[4-(4-吗啉基)吡啶并[3',2':4,5]呋喃并[3,2-D]嘧啶-2-基]苯基]-3-吡啶甲酰胺
|
371942-69-7
|
C25H21N7O3
|
PI3-Kinase α Inhibitor 2
|
PI3-Kinase α Inhibitor 2
|
371943-05-4
|
C16H15N3O2S
|
Furo[2,3-b]pyridine-2-carboxylic acid, 3-aMino-, 3-Methylbutyl ester
|
3-氨基呋喃[2,3-B]吡啶-2-甲酸异戊酯
|
371943-09-8
|
C13H16N2O3
|
1H-Pyrrolo[2,3-b]pyridine-2-carboxylicacid,3-amino-,ethylester(9CI)
|
3-氨基-1H-吡咯并[2,3-B]吡啶-2-羧酸乙酯
|
371943-13-4
|
C10H11N3O2
|
Furo[2,3-b]pyridine-2-carboxaMide, 3-[(3-Methoxybenzoyl)aMino]-
|
3-(3-甲氧基苯酰胺)呋喃并[2,3-B]吡啶-2-羧酰胺
|
371944-46-6
|
C16H13N3O4
|
1,2,3-Oxadiazolo[4,5-b]pyrazine-5,6-dione, 4,7-dihydro-
|
|
371944-48-8
|
C4H2N4O3
|
Furo[2,3-b]pyridine-2-carboxylic acid, 3-amino-, ethyl ester (9CI)
|
3-氨基-呋喃并[2,3-B]嘧啶-2-甲酸乙酯
|
371945-06-1
|
C10H10N2O3
|
Pyrido[3',2':4,5]furo[3,2-d]pyriMidin-4(3H)-one, 2-(3-Methoxyphenyl)-
|
2-(3-甲氧基苯基)吡啶并[3,2:4,5]呋喃并[3,2-D]嘧啶-4(3H)-酮
|
371945-16-3
|
C16H11N3O3
|
Pyrido[3',2':4,5]furo[3,2-d]pyriMidin-4(3H)-one, 2-[3-(acetyloxy)phenyl]-
|
3-(4-氧代-3,4-二氢吡啶并[3,2:4,5]呋喃并[3,2-D]嘧啶-2-基)苯乙酸酯
|
371945-23-2
|
C17H11N3O4
|
6-hydroxy-2-(3-nitrophenyl)quinazolin-4(3H)-one
|
6-羟基-2-(3-硝基苯基)喹唑啉-4(3H)-酮
|
371946-32-6
|
C14H9N3O4
|
3-(4-Oxo-3,4-dihydroquinazolin-2-yl)phenyl acetate
|
3-(4-氧代-3,4-二氢喹唑啉-2-基)苯基乙酸酯
|
371947-93-2
|
C16H12N2O3
|
4,6(1H,5H)-Pyrimidinedione,5,5-diethyl-1-methyl-2-(methylamino)-(9CI)
|
|
371952-49-7
|
C10H17N3O2
|
METHYL 6-AMINO-5-CYANO-4-(4-FLUOROPHENYL)-2-(2-METHOXY-2-OXOETHYL)-4H-PYRAN-3-CARBOXYLATE
|
6-氨基-5-氰基-4-(4-氟苯基)-2-(2-甲氧基-2-氧乙基)-4H-吡喃-3-羧酸甲酯
|
371956-08-0
|
C17H15FN2O5
|
N-(4,6-Dimethylpyrimidin-2-yl)azepane-1-carboximidamide
|
N-(4,6-二甲基嘧啶-2-基)高哌啶-1-甲酰亚胺酰胺
|
371958-52-0
|
C13H21N5
|
Benzoic acid, 4-[(2-methylpropyl)amino]- (9CI)
|
4-(异丁基氨基)苯甲酸
|
371958-90-6
|
C11H15NO2
|
Norneosildenafil
|
那莫西地那非
|
371959-09-0
|
C22H29N5O4S
|
4,4-DIFLUORO-1-(4-FLUORO-PHENYL)-BUTANE-1,3-DIONE
|
4,4-二氟-1-(4-氟苯基)丁烷-1,3-二酮
|
371967-21-4
|
C10H7F3O2
|
1-(4-BROMO-PHENYL)-4,4-DIFLUOROBUTANE-1,3-DIONE
|
1-(4-溴苯基)-4,4-二氟丁烷-1,3-二酮
|
371967-22-5
|
C10H7BrF2O2
|
2-OXO-4-TRIFLUOROMETHYL-2,5,6,7-TETRAHYDRO-1H-[1]PYRIDINDINE-3-CARBONITRILE
|
2-氧代-4-(三氟甲基)-2,5,6,7-四氢-1H-环五[B]吡啶-3-甲腈
|
371967-27-0
|
C10H7F3N2O
|
1H-Indole-4,7-dione, 2-ethyl-3,5,6-trimethyl- (9CI)
|
|
371969-84-5
|
C13H15NO2
|
N-Tosyl-α-methylbenzenemethaneamine
|
4 -甲基-N-(1- 苯基乙基)苯磺酰胺
|
371970-56-8
|
C15H17NO2S
|
N-CarboMethoxyaMoxapine
|
N-CarboMethoxyaMoxapine
|
371971-25-4
|
C19H18ClN3O3
|
TERT-BUTYL-(2S,4R)-N'-(BENZYLOXYCARBONYL)-N'-(BENZYLOXYCARBONYL)-4-HYDROXYORNITHINATE
|
|
371972-14-4
|
C22H34N2O7
|
Benzyl-(1H-iMidazol-2-ylMethyl)-phenyl-aMine, N-Benzyl-N-(1H-iMidazol-2-ylMethyl)-aniline
|
Benzyl-(1H-iMidazol-2-ylMethyl)-phenyl-aMine, N-Benzyl-N-(1H-iMidazol-2-ylMethyl)-aniline
|
371974-08-2
|
C17H17N3
|
tert-butyl 4-hydroxy-4-vinylpiperidine-1-carboxylate
|
1-BOC-4-乙烯基-4-羟基哌啶
|
371975-46-1
|
C12H21NO3
|
L-3-Thiobutyrine
|
|
371976-09-9
|
C4H9NO2S
|
trans-Tramadol(Tramadol impurity)
|
|
371977-05-8
|
C16H25NO2
|
1H-Imidazo[1,5-b]indazole (9CI)
|
|
371978-45-9
|
C9H7N3
|
Spiro[2.4]heptane-1-carboxylic acid, 4-oxo- (9CI)
|
4-氧代螺[2.4]庚烷-1-羧酸
|
371979-98-5
|
C8H10O3
|
Spiro[2.4]heptane-1,4-dicarboxylic acid, 4-amino-, (4S)- (9CI)
|
|
371980-01-7
|
C9H13NO4
|
Spiro[2.4]heptane-1,4-dicarboxylic acid, 4-amino-, (4R)- (9CI)
|
|
371980-02-8
|
C9H13NO4
|
(5R,7R)-rel-7-[[4-(2,6-Dichlorophenyl)-1-piperidinyl]methyl]-6,7,8,9-tetrahydro-1-methyl-5H-benzocyclohepten-5-ol hydrochloride
|
(5R,7R)-REL-7-[[4-(2,6-二氯苯基)-1-哌啶基]甲基]-6,7,8,9-四氢-1-甲基-5H-苯并环庚烯-5-醇盐酸盐
|
371980-94-8
|
C24H30Cl3NO
|
7-[[4-(2,6-Dichlorophenyl)-1-piperidinyl]methyl]-6,7,8,9-tetrahydro-1-methyl-5H-benzocyclohepten-5-olhydrochloride
|
(5S,7S)-7-[[4-(2,6-二氯苯基)-1-哌啶基]甲基]-6,7,8,9-四氢-1-甲基-5H-苯并环庚烯-5-醇
|
371980-98-2
|
C24H29Cl2NO
|
3-(2,6-dichlorophenyl)pentanedioic acid
|
3-(2,6-二氯苯基)戊二酸
|
371981-21-4
|
C11H10Cl2O4
|
4-(2,6-dichloro-phenyl)-piperidine hydrochloride
|
371981-23-6
|
371981-23-6
|
C11H14Cl3N
|
Cintredekin besudotox
|
|
372075-36-0
|
|
Sontuzumab
|
索土珠单抗
|
372075-37-1
|
|
3-trifluoromethyl-1-methyl-1H-5-chloroPyrazole
|
3-三氟甲基-1-甲基-1H-5-氯吡唑
|
372075-75-7
|
C5H4ClF3N2
|
1H-Pyrrolo[1,2-c][1,3]oxazin-1-one,3,4,4a,5-tetrahydro-(9CI)
|
|
372076-11-4
|
C7H9NO2
|
2-Oxazolidinone,3-(1,3-butadienyl)-(9CI)
|
|
372076-13-6
|
C7H9NO2
|
1H-Pyrrolo[1,2-c][1,3]oxazin-1-one,3,4-dihydro-(9CI)
|
|
372076-18-1
|
C7H7NO2
|
5-Methoxy-1-(phenylsulfonyl)-1H-pyrrolo[3,2-b]pyridine
|
5-甲氧基-1-(苯磺酰基)-1H-吡咯并[3,2-B]吡啶
|
372077-49-1
|
C14H12N2O3S
|
3-IODO-6-BROMO INDOLE
|
3-IODO-6-BROMO INDOLE
|
372077-73-1
|
C8H5BrIN
|
2-Oxo-Zoniporide Hydrochloride
|
2-Oxo-Zoniporide Hydrochloride
|
372078-42-7
|
C17H16N6O2
|
5-Hydrazino-2(1H)-quinolinone Hydrochloride
|
5-Hydrazino-2(1H)-quinolinone Hydrochloride
|
372078-45-0
|
C9H10ClN3O
|
5-Cyclopropyl-1-(1,2-dihydro-2-oxo-5-quinolinyl)-1H-pyrazole-4-carboxylic Acid Methyl Ester
|
5-Cyclopropyl-1-(1,2-dihydro-2-oxo-5-quinolinyl)-1H-pyrazole-4-carboxylic Acid Methyl Ester
|
372078-46-1
|
C17H15N3O3
|
5-Cyclopropyl-1-(1,2-dihydro-2-oxo-5-quinolinyl)-1H-pyrazole-4-carboxylic Acid
|
5-Cyclopropyl-1-(1,2-dihydro-2-oxo-5-quinolinyl)-1H-pyrazole-4-carboxylic Acid
|
372078-47-2
|
C16H13N3O3
|
1,1,2,3-tetramethyl-1H-benzo[e]indolium hexafluorophosphate(V)
|
1,1,2,3-四甲基-1H-苯并[E]吲哚六氟磷酸盐
|
372081-65-7
|
C16H18N.F6P
|
Benzeneacetamide, 2-(2-chloro-1-oxopropyl)-alpha-oxo- (9CI)
|
|
372083-31-3
|
C11H10ClNO3
|
7,9-bis[(2-chloro-6-fluorophenyl)methoxy]-2,3-dihydro-1H-cyclopenta[c]chromen-4-one
|
|
372084-88-3
|
C26H18Cl2F2O4
|
1H-Pyrazole-1-carbothioamide,4,5-dihydro-4,4-dimethyl-5-(1-methylethyl)-(9CI)
|
|
372086-98-1
|
C9H17N3S
|
1,4-Naphthalenedione,2-ethoxy-3-hydroxy-(9CI)
|
|
372087-87-1
|
C12H10O4
|
2(1H)-Quinazolinone,1-ethoxy-4-methyl-,3-oxide(9CI)
|
|
372088-42-1
|
C11H12N2O3
|
6-BROMO-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER
|
6-溴吲哚-2-甲酸甲酯
|
372089-59-3
|
C10H8BrNO2
|
Carbamic acid, 1,2,3-thiadiazol-5-yl-, 1,1-dimethylethyl ester (9CI)
|
|
372089-60-6
|
C7H11N3O2S
|
Cyclopropanecarboxamide, 2-bromo-N-cyclopentyl-1-methyl- (9CI)
|
|
372089-85-5
|
C10H16BrNO
|
7-benzyl-1,3-dichloro-5,6,7,8-tetrahydro-2,7-naphthyridine-4-carbonitrile
|
|
372090-70-5
|
C16H13Cl2N3
|
3(2H)-Pyridazinone,1,6-dihydro-6-thioxo-,hydrazone(9CI)
|
|
372091-12-8
|
C4H6N4S
|
1H-Pyrrolo[2,3-c]pyridine, 1-hydroxy-, 6-oxide (9CI)
|
|
372091-74-2
|
C7H6N2O2
|
Parent nucleus of cefotiaM hydrochloride
|
盐酸头孢替安母核
|
372092-19-8
|
C13H21N7O3S2
|
5-Pyridin-3-yl-thiazol-2-ylaMine
|
5-(吡啶-3-基)噻唑-2-胺
|
372096-52-1
|
C8H7N3S
|
3-AMino-N-(p-tolyl)benzenesulfonaMide
|
3-氨基-N-(对甲苯基)苯磺酰胺
|
372096-56-5
|
C13H14N2O2S
|
Carbamic acid, (1,3-diphenyl-1H-pyrazol-4-yl)-, 1,1-dimethylethyl ester (9CI)
|
|
372098-49-2
|
C20H21N3O2
|
1H-Indole-6-carboxylicacid,4-ethoxy-,methylester(9CI)
|
|
372099-86-0
|
C12H13NO3
|
1H-Indole-6-methanol,4-ethoxy-1-ethyl-(9CI)
|
|
372099-99-5
|
C13H17NO2
|
1H-Indole-6-carboxaldehyde,4-ethoxy-1-ethyl-(9CI)
|
|
372100-00-0
|
C13H15NO2
|
4-Pyridinecarboxylicacid,2-amino-3-cyano-5,6-dimethyl-,methylester(9CI)
|
|
372103-87-2
|
C10H11N3O2
|
4-Pyridinecarboxylicacid,2-amino-3-cyano-5-methyl-,methylester(9CI)
|
|
372103-88-3
|
C9H9N3O2
|
naMitecan
|
372105-27-6
|
372105-27-6
|
C23H22N4O5
|
N-HYDROXY-5-METHYLTHIOPHENE-2-CARBOXAMIDINE
|
N'-羟基-5-甲基噻吩-2-甲脒
|
372106-90-6
|
C6H8N2OS
|
3-(4-FORMYL-3-THIEN-2-YL-1H-PYRAZOL-1-YL)PROPANENITRILE
|
3-[4-甲酰基-3-(噻吩-2-基)-1H-吡唑-1-基]丙腈
|
372107-06-7
|
C11H9N3OS
|
1-PHENYL-3-THIEN-2-YL-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
1-苯基-3-(噻吩-2-基)-1H-吡唑-4-羧酸
|
372107-08-9
|
C14H10N2O2S
|
3-(4-CHLORO-PHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
3-(4-氯-苯基)-1-苯基-1H-吡唑-4-羧酸
|
372107-14-7
|
C16H11ClN2O2
|
3-(4-ETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
3-(4-乙基苯基)-1-苯基-1H-吡唑-4-羧酸
|
372107-16-9
|
C18H16N2O2
|
3-(4-METHOXY-PHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
3-(4-甲氧基苯基)-1-苯基-1H-吡唑-4-羧酸
|
372107-36-3
|
C17H14N2O3
|